Clinical trials
Obstructive Pulmonary Disease clinical trials
Below are recruiting obstructive pulmonary disease clinical trials, each written for real people, not researchers. We’re tracking 344 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05297279Recruiting
Omega-3 diet program for people with COPD
This trial tests whether increasing omega-3 (from diet and/or supplements) helps people with COPD. It enrolls people with low omega-3 intake and asks them to follow a specific dietary plan during the study.
Baltimore, MarylandAges 40 years+ - NCT05196698Recruiting
Home high-flow oxygen after COPD hospital flare
This study tests whether using a special oxygen device at home helps prevent another acute COPD flare after you’ve been hospitalized. It’s mainly for people with severe breathing problems who may need oxygen support long-term.
RouenAges 18–85 - NCT05061368RecruitingPhase 2
Sildenafil by mouth to improve breathing in COPD
This Phase 2 trial tests whether sildenafil tablets can improve exercise ability, shortness of breath, and heart-lung function in people with COPD. It also compares against people without COPD to better understand how sildenafil affects breathing tests.
Edmonton, AlbertaAges 40–80 - NCT05008081Recruiting
Study for COPD flare-ups given standard rescue medicines
This study looks at people hospitalized for a COPD flare-up (“exacerbation”). It may help improve how flare-ups are treated because participants need to receive the usual rescue medicines like steroids and/or antibiotics and then follow a study plan.
LinzAges 18 years+ - NCT04722835Recruiting
Study lung immune cells in people at risk for COPD
This study looks at different lung immune cell patterns and how they work in smokers who are not yet diagnosed with COPD or asthma. It may help researchers understand why some people are more likely to develop COPD, which could guide future prevention or early treatments.
San Francisco, CaliforniaAges 40–75 - NCT03888300Recruiting
Measuring the stickiness of lung mucus in breathing problems
This study measures how thick and stretchy (elastic) lung mucus is. It may help researchers better understand mucus in people with obstructive lung breathing problems.
BrusselsAges 18 years+ - NCT03799354Recruiting
Strength training study for people with COPD
This trial tests whether a maximal strength training program can help people with COPD who are stable. It is looking at people with moderate-to-severe airflow limitation and excludes several other lung and health problems.
Lumezzane, BresciaAges 50–80 - NCT00307281Recruiting
Emphysema and COPD patient registry with sample storage
This study enrolls people who have emphysema/COPD into a research registry and collects health information and biological samples. It may help researchers understand the disease better and improve future treatments.
Pittsburgh, PennsylvaniaAges 21 years+ - NCT07701096Enrolling by invitation
Home breathing support monitoring for advanced COPD
This study tests a home monitoring system that watches how well noninvasive breathing support (a mask that helps you breathe) works for people with severe COPD. The system sends early warnings to your care team if your breathing patterns change, which may help prevent flare-ups.
BeijingAges 18 years+ - NCT02755974Recruiting
Study of COPD flare-ups in adults with reduced lung function
This study follows people with COPD flare-ups (sudden worsening of breathing) to better understand what happens and what might help. You may be asked for consent and lung-function tests if you meet the breathing and age requirements.
LondonAges 40–100 - NCT07789899RecruitingPhase 1
Safety study of a new investigational drug in healthy volunteers
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
CambridgeAges 18–55 - NCT07780656RecruitingPhase 3
Felcorekibart for chronic obstructive pulmonary disease (COPD)
This study tests a new medicine, felcorekibart, to see if it can reduce COPD flare-ups better than a placebo after 52 weeks. It's designed for people with high eosinophils, a type of white blood cell linked to inflammation.
Miami, FloridaAges 40–80 - NCT07780669RecruitingPhase 3
Study of a new drug for moderate to severe COPD in smokers
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
Doral, FloridaAges 40–80 - NCT05730088Recruiting
Helping COPD patients avoid hospital visits with home nursing support
This trial tests whether adding several nursing check-ins and coaching (using home oxygen and regular contact) can help people with severe COPD avoid going back to the hospital. It uses phone or internet tools to support care at home.
KonyaAges 18 years+ - NCT06810323Recruiting
Oxygen therapy study for COPD patients
This study tests a long-term oxygen therapy program for people with COPD who already use continuous oxygen at home. The goal is to see if regular at-home oxygen use improves breathing and quality of life over time.
Charlottesville, VirginiaAges Any age - NCT06283004Recruiting
Walking training in COPD: comparing different slopes
This study tests whether walking on different types of slopes improves exercise ability in people with COPD. It aims to find the best slope training to help you breathe easier and walk farther.
Istanbul, Eyüp SultanAges 40 years+ - NCT06644898Recruiting
Walking on slopes to improve balance in COPD
This study tests whether walking on different slopes (like hills) can help people with COPD improve their balance. It compares different types of incline walking to see which works best.
Istanbul, Eyüp SultanAges 40 years+ - NCT06755008Recruiting
Cell repair for lung health in COPD
This study tests whether special stem cells can help repair lung damage in people with COPD. It may help us understand how to improve lung function for those who smoke or have smoked.
Montpellier, HéraultAges 18 years+ - NCT05704881Recruiting
Using breath CO2 levels to judge COPD flare severity in ER
This study measures an easy breathing signal called end-tidal carbon dioxide (a CO2 reading from your exhaled breath) to help judge how severe a COPD flare is. It may help doctors decide how closely you need monitoring and treatment during emergency care.
Grenoble, IsèreAges 18 years+ - NCT05265299RecruitingPhase 3
Testing the right aspirin dose for COPD symptoms
This Phase 3 trial studies which aspirin dose works best in people with COPD, with the goal of improving disease control. You may be asked to take aspirin and be monitored for safety, especially bleeding risk and heart/brain history.
Baltimore, MarylandAges 40–80 - NCT07835945Recruiting
Testing blood gas from artery vs fingertip in breathing distress
This trial compares blood drawn from an artery (arterial blood gas) with blood from a fingertip (capillary blood gas) to see if the fingertip test gives accurate enough results for patients in the emergency room with breathing problems caused by COPD or heart failure. It might help reduce the pain and discomfort of repeated artery tests.
NiceAges 18 years+ - NCT07638176Recruiting
Better breathing support during lung surgery
This study tests whether adjusting breathing machine settings during lung surgery improves oxygen levels and recovery. If you're having lung surgery, this trial may help doctors keep you safer during the procedure.
SeoulAges 19–100 - NCT05854563Recruiting
Study using collected cough samples to learn about lung disease
This trial looks at “cough capture” samples to better understand what is happening in the lungs. You might be eligible if you’re having a bronchoscopy for medical reasons and don’t already have lung cancer.
The Bronx, New YorkAges 21 years+ - NCT07356076Recruiting
Using electrical impedance tomography to look at lung disease
This study uses a special imaging test called electrical impedance tomography (EIT) to look at how well the lungs work in people with lung diseases like COPD, asthma, pneumonia, or long-term effects from COVID-19. It also includes healthy volunteers to compare results.
OlomoucAges 18 years+
Hear when a new Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obstructive pulmonary disease?
- Yes. Clin2 currently lists 344 recruiting obstructive pulmonary disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obstructive pulmonary disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obstructive pulmonary disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.